Anika Therapeutics (ANIK +4.6%) agrees to acquire Parcus Medical, a privately-held sports medicine company, for an upfront payment of ~$35M and contingent payment of $60M
Concurrently, agrees to acquire Arthrosurface, a privately-held provider of joint surface and preservation solutions for active patients for an upfront of $60M and additional milestone payment of $40M.
For 2019, Parcus Medical and Arthrosurface is expected to generate revenues of ~$12M – $13M and ~$28M – $30M, respectively.
Anika anticipates both acquisitions will close in Q1 2020
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.